| Jul 31 |
InMode Q2 2024 Earnings Preview
|
| Jul 31 |
InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform
|
| Jul 26 |
Owens & Minor (OMI) Earnings Expected to Grow: Should You Buy?
|
| Jul 25 |
Analysts Estimate InMode (INMD) to Report a Decline in Earnings: What to Look Out for
|
| Jul 25 |
DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer
|
| Jul 23 |
Jefferies cuts InMode to hold, cites macro pressures
|
| Jul 17 |
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling
|
| Jul 11 |
InMode to Report Second Quarter 2024 Financial Results and Hold Conference Call on Aug. 1, 2024
|
| Jun 30 |
InMode Ltd. (NASDAQ:INMD) is favoured by institutional owners who hold 67% of the company
|
| Jun 13 |
InMode: Reversing Previous Shareholder Dilution With Buybacks
|
